Header cover image
  • Investing Ideas
  • /
  • French Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

French Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

OSE Immunotherapeutics

Market Cap: €143.6m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

OSE

€6.28

7D

21.7%

1Y

-21.2%